MedTrace Logo

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

NCT07045688 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-07-01

No results posted yet for this study

Summary

This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .

Conditions

  • H. Pylori Infection

Interventions

DRUG

Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.

DRUG

Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

DRUG

Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-13
Primary Completion
2025-11-25
Completion
2025-11-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07045688 on ClinicalTrials.gov